Core Laboratories Inc
F:HJ1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (15.6), the stock would be worth €15.56 (14% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 13.7 | €13.7 |
0%
|
| 3-Year Average | 15.6 | €15.56 |
+14%
|
| 5-Year Average | 20.9 | €20.88 |
+52%
|
| Industry Average | 12.1 | €12.05 |
-12%
|
| Country Average | 19.6 | €19.6 |
+43%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
€721.3m
|
/ |
Jan 2026
$59.4m
|
= |
|
|
€721.3m
|
/ |
Dec 2026
$58.9m
|
= |
|
|
€721.3m
|
/ |
Dec 2027
$66.7m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
C
|
Core Laboratories Inc
F:HJ1
|
631.5m EUR | 13.7 | 24.5 | |
| US |
|
Schlumberger NV
NYSE:SLB
|
78.1B USD | 15.1 | 23.4 | |
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
58.4B USD | 16.7 | 22.9 | |
| US |
|
Halliburton Co
NYSE:HAL
|
30.6B USD | 11.9 | 24.8 | |
| LU |
|
Tenaris SA
MIL:TEN
|
25.7B EUR | 12.2 | 16 | |
| UK |
|
TechnipFMC PLC
NYSE:FTI
|
28.1B USD | 20.2 | 30.1 | |
| CN |
|
Yantai Jereh Oilfield Services Group Co Ltd
SZSE:002353
|
120.8B CNY | 33.3 | 43.1 | |
| UK |
|
Subsea 7 SA
OSE:SUBC
|
86.8B NOK | 11.5 | 22.3 | |
| IT |
|
Saipem SpA
MIL:SPM
|
7.6B EUR | 10 | 24.8 | |
| FR |
|
Technip Energies NV
PAR:TE
|
6.9B EUR | 10.8 | 19 | |
| CN |
|
Sinopec Oilfield Service Corp
SSE:600871
|
51B CNY | 39.6 | 77.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
Core Laboratories Inc
Glance View
Core Laboratories, Inc. provides proprietary and patented reservoir description and production enhancement services. The company is headquartered in Houston, Texas and currently employs 3,600 full-time employees. The company went IPO on 2018-10-22. The firm provides services to oil companies. Its reservoir optimization technologies are used to enhance total recovery from existing fields. Its services enable its clients to optimize reservoir performance and maximize hydrocarbon recovery from their producing fields. Its Reservoir Description segment provides laboratory-based analytical and field services to characterize properties of crude oil and crude oil-derived products to the oil and gas industry. In addition, it provides reservoir description capabilities that support various activities associated with energy transition projects, including services that support carbon capture, utilization and storage, hydrogen storage, and geothermal projects. Its Production Enhancement segment includes services and manufactured products associated with reservoir well completions, perforations, stimulation, production and well abandonment.
